Abdominal Operations After Left Ventricular Assist Device Implantation and Heart Transplantation

被引:5
|
作者
Sanaiha, Yas [1 ]
Xing, Hanning [1 ]
Morales, Ricardo Rosales [1 ]
Morchi, Ravi [1 ,2 ]
Ragalie, William [1 ]
Benharash, Peyman [1 ]
机构
[1] Univ Calif Los Angeles, UCLA David Geffen Sch Med, Cardiovasc Outcomes Res Labs CORELAB, Div Cardiac Surg, Los Angeles, CA USA
[2] Univ Calif Orange, Dept Gen Surg, Orange, CA USA
关键词
Orthotopic heart transplantation; Left ventricular assist device; National inpatient sample; Abdominal complications; Emergency general surgery; GASTROINTESTINAL COMPLICATIONS; CARDIAC-SURGERY; NATIONAL TRENDS; CANDIDATES; MORTALITY; OUTCOMES; CARE; ERA;
D O I
10.1016/j.jss.2019.06.045
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Left ventricular assist devices (LVADs) are increasingly used to supplant the limited number of orthotopic heart transplantation (OHT). The present study aimed to perform a contemporary analysis of emergency abdominal operations after LVAD and OHT at a national level. Methods: The 2005-2015 National Impatient Sample, the largest all-payer hospitalization database in the United States, was used to identify all adult patients who had received LVAD or OHT. The primary outcome of interest was the rate of emergency general surgery (EGS), which included laparotomy, small or large bowel resection, peptic ulcer operation, adhesiolysis, and cholecystectomy, during the same hospitalization as LVAD or OHT. Logistic regression was used to determine risk factors for EGS as well as the association between EGS and mortality in both the LVAD and OHT populations. Results: Of the estimated 19,395 OHT and 23,441 LVAD performed, 445 (2.3%) OHT and 719 (3.1%) LVAD patients required EGS. The incidence of EGS in LVAD decreased from 5.4 to 3.3%, whereas it increased among OHT patients from 1.9 to 3.7%, P = 0.003. Occurrence of EGS after OHT and LVAD was associated with significantly higher inpatient risk-adjusted mortality (OHT adjusted odds ratio, 3.0; P = 0.004; LVAD adjusted odds ratio, 2.5; P < 0.001), incremental hospitalization costs (OHT, $ 106,778; P < 0.001; LVAD, $ 61,965; P < 0.001), and length of stay (OHT, 27.9 d; P < 0.001; LVAD, 20.8 d; P < 0.001). Conclusions: EGS remains an infrequent but high mortality and cost complication of OHT and LVAD. Further investigation of the impact of immunosuppression, anticoagulation, and perfusion strategies on incidence of abdominal complications is warranted. (C) 2019 Published by Elsevier Inc.
引用
收藏
页码:481 / 487
页数:7
相关论文
共 50 条
  • [21] Right heart failure after left ventricular assist device implantation: early and late
    MacGowan, Guy A.
    Schueler, Stephan
    CURRENT OPINION IN CARDIOLOGY, 2012, 27 (03) : 296 - 300
  • [22] Right heart failure after left ventricular assist device implantation: a persistent problem
    Chesney Siems
    Rishav Aggarwal
    Andrew Shaffer
    Ranjit John
    Indian Journal of Thoracic and Cardiovascular Surgery, 2023, 39 : 161 - 169
  • [23] Early Ventricular Arrhythmias After Left Ventricular Assist Device Implantation
    Oates, Connor P.
    Lam, Phillip H.
    Lawrence, Luke
    Bigham, Grace
    Meda, Namratha S.
    Basyal, Binaya
    Hadadi, Cyrus A.
    Rao, Sriram D.
    Hockstein, Michael
    Shah, Manish
    Sheikh, Farooq H.
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (08) : 1018 - 1027
  • [24] Reduced Anxiety and Depression in Patients With Advanced Heart Failure After Left Ventricular Assist Device Implantation
    Yost, Gardner
    Bhat, Geetha
    Mahoney, Edward
    Tatooles, Antone
    PSYCHOSOMATICS, 2017, 58 (04) : 406 - 414
  • [25] Right ventricular load adaptability metrics in patients undergoing left ventricular assist device implantation
    Amsallem, Myriam
    Aymami, Marie
    Hiesinger, William
    Zeigler, Sanford
    Moneghetti, Kegan
    Marques, Michael
    Teuteberg, Jeffrey
    Ha, Richard
    Banerjee, Dipanjan
    Haddad, Francois
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 157 (03) : 1023 - +
  • [26] Timing of Temporary Right Ventricular Assist Device Insertion for Severe Right Heart Failure After Left Ventricular Assist Device Implantation
    Takeda, Koji
    Naka, Yoshifumi
    Yang, Jonathan A.
    Uriel, Nir
    Colombo, Paolo C.
    Jorde, Ulrich P.
    Takayama, Hiroo
    ASAIO JOURNAL, 2013, 59 (06) : 564 - 569
  • [27] Changes in Spirometry After Left Ventricular Assist Device Implantation
    Mohamedali, Burhan
    Bhat, Geetha
    Yost, Gardner
    Tatooles, Antone
    ARTIFICIAL ORGANS, 2015, 39 (12) : 1046 - 1050
  • [28] Inhaled Milrinone After Left Ventricular Assist Device Implantation
    Haglund, Nicholas A.
    Burdorf, Adam
    Jones, Tara
    Shostrom, Valerie
    Um, John
    Ryan, Timothy
    Shillcutt, Sasha
    Fischer, Patricia
    Cox, Zachary L.
    Raichlin, Eugenia
    Lowes, Brian D.
    Dumitru, Ioana
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (10) : 792 - 797
  • [29] Anticoagulation Therapy After Left Ventricular Assist Device Implantation
    Tanoue, Yoshihisa
    Fujino, Takeo
    Shiose, Akira
    CIRCULATION JOURNAL, 2018, 82 (05) : 1245 - 1246
  • [30] Left Ventricular Assist Device and Heart Transplantation in Hemophilia A Patient
    Quader, Mohammed
    Rusina, Zane
    Lewis, Neil P.
    Martin, Lisa
    Katlaps, Gundars
    ANNALS OF THORACIC SURGERY, 2013, 96 (06) : 2245 - 2247